cancer-treatment

Documents about cancer-treatment

• Clinical, pathological, treatment, and follow-up data of patients with triple-negative breast cancer treated with carboplatin-containing neoadjuvant chemotherapy#443363Repositório de Dados de Pesquisa da Unicamp Dataverse OAI Archive
• Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers#664978Figshare
• Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers#664979Figshare
• Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study.#785404NCBI PubMed Central
• Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria#807390ClinicalTrials.gov
• Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis#807618ClinicalTrials.gov
• Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment#810641ClinicalTrials.gov
• ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment#261469ClinicalTrials.gov
• Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma#184850ClinicalTrials.gov
• Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors#141018ClinicalTrials.gov
• Trajectoire de la contamination en platine dans les hydrosystèmes français depuis le début du XXe siècle : approche multi-échelles spatio-temporelles#156123HAL (France)
• Additional file 1 of Anticipated barriers and facilitators of implementing a digital behavioral treatment for chronic pain: a qualitative interview study#241913Figshare
• Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.#249611ClinicalTrials.gov
• Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma#272334ClinicalTrials.gov
• Machine learning-based models for predicting the efficacy and safety of recombinant human interleukin-11 in the treatment of cancer therapy-induced thrombocytopenia: exploration and preliminary validation from a multicenter retrospective study.#399634NCBI PubMed Central
• A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI#424183ClinicalTrials.gov
• AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review (2020-present).#425505PubMed
• Emergence of KRAS mosaicism with multiple variants during treatment with alectinib in ALK‑positive metastatic non‑small cell lung cancer: A case report#460839HAL (France)
• Development and usability of the “FORTEe Get Strong” app to promote physical activity and health awareness in children and adolescents with cancer during intensive treatment using an app-based approach : mixed methods study#470038The Learning Edge
• Pembrolizumab-based systemic therapy associated with opportunities for subsequent local treatment in advanced or recurrent neuroendocrine carcinoma of the cervix: a five-case series#477036OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• SRPK1 inhibition and other treatments for acute myeloid leukaemia#483924University of Nottingham Repository
• Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer#805632ClinicalTrials.gov
• Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia#807460ClinicalTrials.gov
• Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer#121329ClinicalTrials.gov
• A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung#18581ClinicalTrials.gov
• Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology#195336ClinicalTrials.gov
• Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients#230357ClinicalTrials.gov
• Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer#279520ClinicalTrials.gov
• Gut Microbiota (GM) Biodiversity in Patients With Solid Tumors Treated With Immune Checkpoint Inhibitors (ICIs): a Monocenter Prospective Study to Identify the Interactions Between GM and ICIs#307436ClinicalTrials.gov
• Primary fibroblasts from BRCA1 mutation-carrying members of breast cancer families display a G1/S cell cycle checkpoint defect following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment.#315241Lancaster EPrints
• Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 – PRODIGE 107 – FFCD 2306 – COLOSOTO trial#670104HAL (France)
• A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and Feasibility#804529ClinicalTrials.gov
• The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer.#156956NCBI PubMed Central
• Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)#158204ClinicalTrials.gov
• Efficacy and Descriptive Safety Assessment of Programmed Cell Death Protein-(Ligand) 1 Inhibitors Plus Chemotherapy as First-Line Treatment for Gastric and Gastroesophageal Junction Cancer in Asian and Non-Asian Patients: A Meta-Analysis.#170800NCBI PubMed Central
• Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer#208427ClinicalTrials.gov
• Evaluating The Direct Medication Costs Associated With Advanced Non-Small Cell Lung Cancer (nsclc) Treatment By Biomarkers In The United States: A Coarsened Exact Matching Retrospective Cohort Study#260903EliScholar
• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL#429746ClinicalTrials.gov
• Genomic characterization of virulence and disinfectant resistant determinants in multidrug-resistant <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> from urban wastewater treatment plants in Windhoek, Namibia#475606Figshare
• Towards individualized treatment planning for PSMA-targeted radioligand therapy of advanced prostate cancer: from in silico determination of the relative biological effectiveness to image-based red bone marrow dosimetry / Mikhail Rumiantcev ; Betreuer: Guido Böning#661773Deutsche Nationalbibliothek
• Role of quantitative ventilation/perfusion scan (qVQ) in the pre-treatment assessment of bronchoscopic lung volume reduction with endobronchial valves (BLVR-EBV) for emphysema and the pre-operative assessment for lung cancer: a systematic review.#685635NCBI PubMed Central
• Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia#807563ClinicalTrials.gov
• An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC)#122039HAL (France)
• DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers#256862ClinicalTrials.gov
• First Real-World Data of Olaparib Combination Treatment with Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC): Descriptive Analysis of 154 Patients Enrolled in the Early Access Program in France.#309136NCBI PubMed Central
• Exploring the in vitro effects of Helichrysum petiolares for its potential to provide cardioprotective benefits against Doxorubicin toxicity#437868SUNScholar
• Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients#804520ClinicalTrials.gov
• Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma#125834ClinicalTrials.gov
• Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma#272360ClinicalTrials.gov
• Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer#279507ClinicalTrials.gov